Drug makers shell out millions to influence Calif. drug-discount vote

Pharmaceutical companies have ponied up $72 million to try to defeat a California ballot initiative that would extend drug discounts to more uninsured people and allow consumers to sue drug makers whose products are sold at "unconscionable" prices." Pfizer, GlaxoSmithKline, Merck and Johnson & Johnson have each given almost $10 million to the campaign. By comparison, the industry contributed just $9.8 million to affect the 2004 federal elections.

- read this report from USA Today for more

Suggested Articles

A phase 3 study of NuCana’s lead drug was halted because a monitoring committee deemed it unlikely to succeed.

The filing follows data from Japanese phase 3 trials that assessed the oral HIF-PHI in chronic kidney disease patients.

The Allen Institute found major differences in human and mouse brain cells, which could guide the design of drugs for brain diseases.